Serum apolipoprotein a determination

Apolipoprotein A1 (ApoA1) is the major structural protein of high density lipoprotein (HDL). Its content can basically reflect how much HDL particles. A decrease in ApoA1 in serum/plasma samples suggests an increased risk of cardiovascular (coronary heart disease) and cerebrovascular (cerebral thrombosis) disease, and is often used as one of the sensitive indicators for risk assessment of cardiovascular and cerebrovascular diseases. Basic Information Specialist classification: cardiovascular examination classification: biochemical examination Applicable gender: whether men and women apply fasting: fasting Tips: It is forbidden to take certain drugs (such as birth control pills, thyroid hormones, steroid hormones, etc.) before the test to affect blood lipid levels. Normal value Immunoturbidimetry: Male: 0.94-1.78g/L. Female: 1.01-1.99g/L. ApoA-I/ApoB. Male: 0.80-2.3. Female: 0.94-2.63. Clinical significance Abnormal results: The measured value of apolipoprotein AI reflects the content of high density lipoprotein. Decreased apolipoprotein AI is considered a risk factor for cardiovascular and cerebrovascular diseases. Increased in alcoholic hepatitis, high alpha lipoproteinemia and so on. Reduced in coronary heart disease, arteriosclerotic disease, uncontrolled diabetes, nephrotic syndrome, malnutrition, active hepatitis or acute hepatitis, chronic hepatitis, cirrhosis, extrahepatic biliary obstruction, artificial dialysis. People who need to be examined: liver cirrhosis, diabetes, malnutrition, cardiovascular and cerebrovascular diseases. Low results may be diseases: hepatitis, coronary heart disease considerations Forbidden before examination: It is forbidden to take certain drugs (such as birth control pills, thyroid hormones, steroid hormones, etc.) to affect blood lipid levels. Requirements for examination: There should be no history of acute illness, injury or surgery in the near future. Inspection process Subjects were venously collected and assayed in time for serum separation. It is determined by immunological transmission (or scattering) turbidimetry. Not suitable for the crowd 1. Patients who have taken contraceptives, thyroid hormones, steroid hormones, etc., may affect the results of the examination and prohibit patients who have recently taken the drug history. 2, special diseases: patients with hematopoietic function to reduce disease, such as leukemia, various anemia, myelodysplastic syndrome, etc., unless the examination is essential, try to draw less blood. Adverse reactions and risks 1, subcutaneous hemorrhage: due to pressing time less than 5 minutes or blood draw technology is not enough, etc. can cause subcutaneous bleeding. 2, discomfort: the puncture site may appear pain, swelling, tenderness, subcutaneous ecchymosis visible to the naked eye. 3, dizzy or fainting: in the blood draw, due to emotional overstress, fear, reflex caused by vagus nerve excitement, blood pressure decreased, etc. caused by insufficient blood supply to the brain caused by fainting or dizziness.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.